Most Recent
ExxonMobil sues Andrew Forrest-linked NGO for defamation
ExxonMobil has sued an NGO linked to Andrew Forrest, alleging his company Fortescue has “orchestrated a campaign to compete” by funding lawsuits against it.
Judge slashes contingency fee in Insurance Australia class action
A judge has cut Slater & Gordon's 33% contingency fee in a class action against Insurance Australia, saying it was too high since there was nothing "particularly novel” about the case.
Construction PRO
Lander & Rogers faces client lawsuit over $2.9M bill
A former Lander & Rogers client that was hit with a $2.9 million legal bill for work on a construction matter has taken the firm to court, calling its costs disclosures “grossly inadequate”. 
Tenth junior doctors class action filed after run of court wins
Law firm Gordon Legal has filed a tenth class action on behalf of junior doctors in Victoria who were allegedly underpaid for shift work, after several landmark wins in similar cases. 
GM hit with class action over allegedly defective Holden transmissions
General Motors is facing a class action over Holden vehicles allegedly fitted with faulty transmission systems over the last 13 years. 
Another judge overturns decision for uncritical copying and pasting
In the latest case of a ruling being reversed for copying and pasting, a judge has quashed the AAT’s decision to cancel a student visa for failing to bring an independent mind to the issues.
Construction PRO
High Court asked to weigh in on ‘public purpose’ for land acquisition
Transport for NSW has asked the High Court to weigh in on when land is acquired for a 'public purpose', in a dispute over the value of land acquired near the Western Sydney Airport.
New Zealand’s highest court endorses early common fund orders
ANZ Bank New Zealand has lost its bid to appeal a ruling that common fund orders can be made in class actions, including at an early stage of the proceeding,
Virbac loses bid to block generic animal drug
Animal health company Virbac has lost its interlocutory bid to block a generic version of its animal drug Cydectin Platinum by rival Abbey Laboratories.